Back to top

Image: Bigstock

Company News For Nov 27, 2018

Read MoreHide Full Article
  • Zafgen, Inc.’s shares plummeted 40.6% after the FDA put U.S. trials of the company’s experimental diabetes drug on hold, citing safety concerns
  • Shares of Cleveland-Cliffs Inc. (CLF - Free Report) declined 1.3% after it announced a new $200 million stock buyback program
  • Aetna. Inc.’s shares gained 2.3% after CVS Health Corporation (CVS - Free Report) received the final regulatory nod to acquire the company
  • Shares of GW Pharmaceuticals plc increased 2.9% after the company announced positive top-line results for its cannabinoid-based childhood-onset epilepsy treatment, Epidiolex

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Cleveland-Cliffs Inc. (CLF) - free report >>

CVS Health Corporation (CVS) - free report >>

Published in